Mitochondrial oxidative stress and dysfunction in arsenic neurotoxicity: A review

Journal of Applied Toxicology

Volumn 36, Issue 2, 2016, Pages 179-188

  Prakash, Chandra ^a   Soni, Manisha ^a   Kumar, Vijay ^a  

^a MAHARSHI DAYANAND UNIVERSITY   (India)

Author keywords

Arsenic; Membrane potential; Mitochondrial dysfunction; Neurotoxicity; Oxidative stress

Indexed keywords

ANTIOXIDANT; ARSENIC DERIVATIVE; ARSENIC TRIOXIDE; ARSENITE SODIUM; CALCIUM; CHELATING AGENT; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; BRAIN MITOCHONDRION; CALCIUM HOMEOSTASIS; CELL DEATH; CELL ENERGY; CELL METABOLISM; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; HUMAN; MEMBRANE POTENTIAL; NEUROTOXICITY; NONHUMAN; OXIDATION KINETICS; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; ANIMAL; ARSENIC POISONING; BRAIN; DRUG EFFECTS; MITOCHONDRION; PATHOPHYSIOLOGY; RAT; TOXICITY AND INTOXICATION;

ANIMALS; ARSENIC POISONING; BRAIN; MITOCHONDRIA; NEUROTOXICITY SYNDROMES; OXIDATIVE STRESS; RATS; SUPEROXIDE DISMUTASE;

EID: 84954391032     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.3256     Document Type: Review

References (115)

1. Andersen O. 1999. Principles and recent developments in chelation treatment of metal intoxication. Chem. Rev. 99: 2683-2710.
2. Aung KH, Kurihara R, Nakashima S, Maekawa F, Nohara K, Kobayashi T, Tsukahara S. 2013. Inhibition of neurite outgrowth and alteration of cytoskeletal gene expression by sodium arsenite. Neurotoxicology 34: 226-235.
3. Batandier C, Fontaine E, Keriel C, Leverve XM. 2002. Determination of mitochondrial reactive oxygen species: methodological aspects. J. Cell. Mol. Med. 6: 175-187.
4. Beal MF. 1996. Mitochondria, free radicals, and neurodegeneration. Curr. Opin. Neurobiol. 6: 661-666.
5. Benov LC, Benchev IC, Monovich OH. 1990. Thiol antidotes effect on lipid peroxidation in mercury poisoned rats. Chem. Biol. Interact. 76: 321-332.
6. Benov LC, Ribarov SR, Monovich OH. 1992. Study of activated oxygen production by some thiols using chemiluminescence. Gen. Physiol. Biophys. 11: 195-202.
7. Bhattacharjee P, Chatterjee D, Singh KK, Giri AK. 2013. Systems biology approaches to evaluate arsenic toxicity and carcinogenicity: An overview. Int. J. Hyg. Environ. Health 216: 574-586.
8. Brinkel J, Khan MMH, Kraemer A. 2009. A systematic review of arsenic exposure and its social and mental health effects with special reference to Bangladesh. Int. J. Environ. Res. Public Health 6: 1609-1619.
9. Calderon J, Navarro ME, Jiminez-Capdeville ME, Santos-Diaz MA, Golden A, Rodriguez-Leyva I, Borja-Aburto V, Diaz-Barriga F. 2001. Exposure to arsenic and lead and neuropsychological development in Mexican children. Environ. Res. 85: 69-76.
10. Chattopadhyay S, Bhaumik S, Nag Chaudhury A, Das GS. 2002a. Arsenic induced changes in growth development and apoptosis in neonatal and adult brain cells in vivo and in tissue culture. Toxicol. Lett. 128: 73-84.
11. Chattopadhyay S, Bhaumik S, Purkayastha M, Basu S, Nag Chaudhuri A, Das GS. 2002b. Apoptosis and necrosis in developing brain cells due to arsenic toxicity and protection with antioxidants. Toxicol. Lett. 136: 65-76.
12. Chaudhuri AN, Basu S, Chattopadhyay S, Das GS. 1999. Effect of high arsenic content in drinking water on rat brain. Indian J. Biochem. Biophys. 36: 51-54.
13. Chen YC, Lin-Shiau SY, Lin JK. 1998. Involvement of reactive oxygen species and caspase 3 activation in arsenite induced apoptosis. J. Cell. Physiol. 177: 324-333.
14. Cheng TJ, Wang YJ, Kao WW, Chen RJ, Ho YS. 2007. Protection against arsenic trioxide-induced autophagic cell death in U118 human glioma cells by use of lipoic acid. Food Chem. Toxicol. 45: 1027-1038.
15. Dwivedi N, Mehta A, Yadav A, Binukumar BK, Gill KD, Flora SJS. 2011. MiADMSA reverses impaired mitochondrial energy metabolism and neuronal apoptotic cell death after arsenic exposure in rats. Toxicol. Appl. Pharmacol. 256: 241-248.
16. Edwards M, Hall J, Gong G, O'Bryant S. 2014. Arsenic exposure, AS3MT polymorphism, and neuropsychological functioning among rural dwelling adults and elders: a cross-sectional. Environ. Health 13: 15.
17. Esposito E, Rotilio D, Di Matteo V, Di Giulio C, Cacchio M, Algeri S. 2002. A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiol. Aging 23: 719-735.
18. Falkenberg M, Larsson NG, Gustafsson CM. 2007. DNA replication and transcription in mammalian mitochondria. Annu. Rev. Biochem. 76: 679-699.
19. Finkel T. 2011. Signal transduction by reactive oxygen species. J. Cell Biol. 194: 7-15.
20. Flora SJS. 1999. Arsenic-induced oxidative stress and its reversibility following combined administration of n-acetylcysteine and meso 2, 3-dimercaptosuccinic acid in rats. Clin. Exp. Pharmacol. Physiol. 26: 865-869.
21. Flora SJS, Tandon SK. 1990. Beneficial effects of zinc supplementation during chelation treatment of lead intoxication in rats. Toxicology 64: 129-139.
22. Flora SJS, Bhadauria S, Pant SC, Dhaked RK. 2005. Arsenic induced blood and brain oxidative stress and its response to some thiol chelators in rats. Life Sci. 77: 2324-2337.
23. Flora SJS, Bhadauria S, Kannan GM, Singh N. 2007. Arsenic induced oxidative stress and the role of antioxidant supplementation during chelation: A review. J. Environ. Biol. 28: 333-347.
24. Flora SJS, Bhatt K, Mehta A. 2009. Arsenic moiety in gallium arsenide is responsible for neuronal apoptosis and behavioral alterations in rats. Toxicol. Appl. Pharmacol. 240: 236-244.
25. Flora SJS, Dwivedi N, Deb U, Kushwaha P, Lomash V. 2014. Effects of co-exposure to arsenic and dichlorvos on glutathione metabolism, neurological, hepatic variables and tissue histopathology in rats. Toxicol. Res. 3: 23-31.
26. 3) induced calcium signals and cytotoxicity in two human cell lines: SY-5Y neuroblastoma and 293 embryonic kidney (HEK). Toxicol. Appl. Pharmacol. 220: 292-301.
27. Garcia-Chavez E, Santamaria A, Diaz-Barriga F, Mandeville P, Juarez BI, Jimenez-Capdeville ME. 2003. Arsenite-induced formation of hydroxyl radical in the striatum of awake rats. Brain Res. 976: 82-89.
28. Gerr F, Letz R, Green RC. 2000a. Relationships between quantitative measures and neurologist's clinical rating of tremor and standing steadiness in two epidemiological studies. Neurotoxicology 21: 753-760.
29. Gerr F, Letz R, Ryan PB, Green RC. 2000b. Neurological effects of environmental exposure to arsenic in dust and soil among humans. Neurotoxicology 21: 475-487.
30. Gersl V, Hrdina R, Vavrova J, Holeckova M, Palicka V, Voglova J, Mazurova Y, Bajgar J. 1997. Effects of repeated administration of dithiol chelating agent - sodium 2, 3-dimercapto-1-propanesulphonate (DMPS) - on biochemical and haematological parameters in rabbits. Acta Medica (Hradec Kralove) 40: 3-8.
31. Ghosh S, Dungdung SR, Chowdhury ST, Mandal AK, Sarkar S, Ghosh D, Das N. 2011. Encapsulation of the flavonoid quercetin with an arsenic chelator into nanocapsules enables the simultaneous delivery of hydrophobic and hydrophilic drugs with a synergistic effect against chronic arsenic accumulation and oxidative stress. Free Radic. Biol. Med. 51: 1893-1902.
32. Giasson BI, Sampathu DM, Wilson CA, Vogelsberg-Ragaglia V, Mushynski WE, Lee VML. 2002. The Environmental toxin arsenite induces tau hyperphosphorylation. Biochemistry 41: 15376-15387.
33. Gibson GE, Chen H-L, Xu H, Qiu L, Xu Z, Denton TT, Shi Q. 2012. Deficits in the mitochondrial enzyme alpha-ketoglutarate dehydrogenase lead to Alzheimer's disease-like calcium dysregulation. Neurobiol. Aging 33: 1121e13-24.
34. Gong G, O'Bryant SE. 2010. The arsenic exposure hypothesis for Alzheimer disease. Alzheimer Dis. Assoc. Disord. 24: 311-316.
35. Gong G, Hargrave K, Hobson V, Spallholz J, Boylan M, Lefforge D, O'Bryant S. 2011. Low-level groundwater arsenic exposure impacts cognition: a project FRONTIER study. J. Environ. Health 74: 16-22.
36. Gopalkrishnan A, Rao MV. 2006. Amelioration by vitamin A upon arsenic induced metabolic and neurotoxic effects. J. Health Sci. 52: 568-577.
37. Green DR, Reed JC. 1998. Mitochondria and apoptosis. Science 281: 1309-1312.
38. 3)-induced apoptosis in human glioblastoma cells. Cancer Sci. 96: 825-833.
39. Han YH, Kim SZ, Kim SH, Park WH. 2008. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH. Cancer Lett. 270: 40-55.
40. Herrera A, Pineda J, Antonio MT. 2013. Toxic effects of perinatal arsenic exposure on the brain of developing rats and the beneficial role of natural antioxidants. Environ. Toxicol. Pharmacol. 36: 73-79.
41. Hong Y, Piao F, Zhao Y, Li S, Wang Y, Liu P. 2009. Subchronic exposure to arsenic decreased Sdha expression in the brain of mice. Neurotoxicology 30: 538-543.
42. Hughes MF. 2002. Arsenic toxicity and potential mechanisms of action. Toxicol. Lett. 133: 1-16.
43. Ivanov VN, Hei TK. 2013. Induction of apoptotic death and retardation of neuronal differentiation of human neural stem cells by sodium arsenite treatment. Exp. Cell Res. 319: 875-887.
44. Jiang S, Su J, Yao S, Zhang Y, Cao F, Wang F, Wang H, Li J, Xi S. 2014. Fluoride and arsenic exposure impairs learning and memory and decreases mGluR5 expression in the hippocampus and cortex in rats. PLoS One 9: e96041.
45. Jing J, Zheng G, Liu M, Shen X, Zhao F, Wang J, Zhang J, Huang G, Dai P, Chen Y, Chen J, Luo W. 2012. Changes in the synaptic structure of hippocampal neurons and impairment of spatial memory in a rat model caused by chronic arsenite exposure. Neurotoxicology 33: 1230-1238.
46. Jomova K, Valko M. 2011. Advances in metal-induced oxidative stress and human disease? Toxicology 283: 65-87.
47. Jomova K, Jenisova Z, Feszterova M, Baros S, Liska J, Hudecova D, Rhodes CJ, Valko M. 2011. Arsenic: toxicity, oxidative stress and human disease. J. Appl. Toxicol. 31: 95-107.
48. Kadeyala PK, Sannadi S, Gottipolu RR. 2013. Alterations in apoptotic caspases and antioxidant enzymes in arsenic exposed rat brain regions: reversal effect of essential metals and a chelating agent. Environ. Toxicol. Pharmacol. 36: 1150-1166.
49. Kaler S, Dhar P, Bhattacharya A, Mehra RD. 2013. Preliminary morphological and immunohistochemical changes in rat hippocampus following postnatal exposure to sodium arsenite. Toxicol. Int. 20: 160-169.
50. Kannan GM, Tripathi N, Dube SN, Gupta M, Flora SJS. 2001. Toxic effects of arsenic(III) on some hematopoietic and central nervous system variables in rats and guinea pigs. J. Toxicol. Clin. Toxicol. 39: 675-682.
51. Kaur H, Mishra D, Bhatnagar P, Kaushik P, Flora SJS. 2009. Co-administration of α-Lipoic acid and vitamin C protects liver and brain oxidative stress in mice exposed to arsenic contaminated water. Water Qual. Expo. Health 1: 135-144.
52. Kobayashi H, Yuyama A, Ishihara M, Matsusaka N. 1987. Effects of arsenic on cholinergic parameters in brain in vitro. Neuropharmacology 26: 1707-1713.
53. Koya RC, Fujita H, Shimizu S, Ohtsu M, Takimoto M, Tsujimoto Y, Kuzumaki N. 2000. Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release. J. Biol. Chem. 275: 15343-15349.
54. Kroemer G. 1999. Mitochondrial control of apoptosis: an overview. Biochem. Soc. Symp. 66: 1-15.
55. Larochette N, Decaudin D, Jacotot E, Brenner C, Marzo I, Susin SA, Zamzami N, Xie Z, Reed J, Kroemer G. 1999. Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Exp. Cell Res. 249: 413-421.
56. Le Quesne PM, McLeod JG. 1977. Peripheral neuropathy following a single exposure to arsenic: Clincal course in four patients with electrophysiological and histological studies. J. Neurol. Sci. 32: 437-451.
57. Lee JE, Park JH, Shin IC, Koh HC. 2012. Reactive oxygen species regulated mitochondria-mediated apoptosis in PC12 cells exposed to chlorpyrifos. Toxicol. Appl. Pharmacol. 263: 148-162.
58. Li X, Chan L, Zhang H, Zhang H2, Niu Q. 2014. Effects of arsenic poisoning on neuronal cell apoptosis and mRNA and protein expression of calpain 1, calpain 2, and cdk5/p25. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 32: 202-206.
59. Liu J, Killilea DW, Ames BN. 2002. Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substratebinding affinity and activity in brain by feeding old rats acetyl-L-carnitine and/or R-alpha-lipoic acid. Proc. Natl. Acad. Sci. U. S. A. 99: 1876-1881.
60. Liu SY, Wen CY, Lee YJ, Lee TC. 2010. XPC silencing sensitizes glioma cells to arsenic trioxide via increased oxidative damage. Toxicol. Sci. 116: 183-193.
61. Lobo V, Patil A, Phatak A, Chandra N. 2010. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn. Rev. 4: 118-126.
62. Lu TH, Hsieh SY, Yen CC, Wu HC, Chen KL, Hung DZ, Chen CH, Wu CC, Su YC, Chen YW, Liu SH, Huang CF. 2011. Involvement of oxidative stress-mediated ERK1/2 and p38 ctivation regulated mitochondria-dependent apoptotic signals in methylmercury-induced neuronal cell injury. Toxicol. Lett. 204: 71-80.
63. Lu TH, Tseng TJ, Su CC, Tang FC, Yen CC, Liu YY, Yang CY, Wu CC, Chen KL, Hung DZ, Chen YW. 2014. Arsenic induces reactive oxygen species-caused neuronal cell apoptosis through JNK/ERK-mediated mitochondria-dependent and GRP 78/CHOP-regulated pathways. Toxicol. Lett. 224: 130-140.
64. Luo JH, Qiu ZQ, Shu WQ, Zhang YY, Zhang L, Chen JA. 2009. Effects of arsenic exposure from drinking water on spatial memory, ultra-structures and NMDAR gene expression of hippocampus in rats. Toxicol. Lett. 184: 121-125.
65. Luo JH, Qiu ZQ, Zhang L, Shu WQ. 2012. Arsenite exposure altered the expression of NMDA receptor and postsynaptic signaling proteins in rat hippocampus. Toxicol. Lett. 211: 39-44.
66. Martin LJ. 2010. The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis. Biochim. Biophys. Acta 102: 186-197.
67. Martin LJ, Al-Abdulla NA, Brambrink AM, Kirsch JR, Sieber FE, Portera-Cailliau C. 1998. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res. Bull. 46: 281-309.
68. Mathew L, Vale A, Adcock JE. 2010. Arsenical peripheral neuropathy. Pract. Neurol. 10: 34-38.
69. Meyer JN, Leung MCK, Rooney JP, Sendoel A, Hengartner MO, Kisby GE, Bess AS. 2013. Mitochondria as a target of environmental toxicants. Toxicol. Sci. 134: 1-17.
70. Mukherjee A, Sengupta MK, Hossain MA, Ahamed S, Das B, Nayak B, Lodh D, Rahman MM, Chakraborti D. 2006. Arsenic contamination in groundwater: a global perspective with emphasis on the Asian scenario. J. Health Popul. Nutr. 24: 142-163.
71. Nagaraja TN, Desiraju T. 1993. Regional alterations in the levels of brain biogenic amines, glutamate, GABA, and GAD activity due to chronic consumption of inorganic arsenic in developing and adult rats. Bull. Environ. Contam. Toxicol. 50: 100-107.
72. Nagaraja TN, Desiraju T. 1994. Effects on operant learning and brain acetylcholine esterase activity in rats following chronic inorganic arsenic intake. Hum. Exp. Toxicol. 13: 353-356.
73. Namgung U, Xia Z. 2000. Arsenite-induced apoptosis in cortical neurons is mediated by c-Jun N-terminal protein kinase 3 and p38 mitogen-activated protein kinase. J. Neurosci. 20: 6442-6451.
74. Namgung U, Xia Z. 2001. Arsenic induces apoptosis in rat cerebellar neurons via activation of JNK3 and p38 MAP kinases. Toxicol. Appl. Pharmacol. 174: 130-138.
75. Northington FJ, Graham EM, Martin LJ. 2005. Apoptosis in perinatal hypoxic-ischemic brain injury: how important is it and should it be inhibited? Brain Res. Rev. 50: 244-257.
76. O'Bryant S, Edwards M, Menon C, Gong G, Barber R. 2011. Long-term low-level arsenic exposure is associated with poorer neuropsychological functioning: a project FRONTIER study. Int. J. Environ. Res. Public Health 8: 861-874.
77. Orrenius S, Zhivotovsky B, Nicotera P. 2003. Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 4: 552-565.
78. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. 2007. Mitochondria, oxidative stress and cell death. Apoptosis 12: 913-922.
79. 2+ dependent and abrogated by chelation therapy: Role of voltage gated calcium channels. Neurotoxicology 35: 137-145.
80. Parvez F, Wasserman GA, Factor-Litvak P, Liu X, Slavkovich V, Siddique AB, Sultana R, Sultana R, Islam LD, Mey JL, van Geen A, Khan K, Kline J, Ahsan H, Graziano JH. 2011. Arsenic exposure and motor function among children in Bangladesh. Environ. Health Perspect. 119: 1665-1170.
81. Piao F, Ma N, Hiraku Y, Murata M, Oikawa S, Cheng F, Zhong L, Yamauchi T, Kawanishi S, Yokoyama K. 2005. Oxidative DNA damage in relation to neurotoxicity in the brain of mice exposed to arsenic at environmentally relevant levels. J. Occup. Health 47: 445-449.
82. Pieczenik SR, Neustadt J. 2007. Mitochondrial dysfunction and molecular pathways of disease. Exp. Mol. Pathol. 83: 84-92.
83. Prakash C, Soni M, Kumar V. 2015. Biochemical and molecular alterations following arsenic-induced oxidative stress and mitochondrial dysfunction in rat brain. Biol. Trace Elem. Res. 167: 121-129.
84. Ram Kumar M, Flora SJS, Reddy GR. 2013. Monoisoamyl 2, 3-dimercaptosuccinic acid attenuates arsenic induced toxicity: behavioral and neurochemical approach. Environ. Toxicol. Pharmacol. 36: 231-242.
85. 2+ influx upregulate calpain and induce apoptosis in PC12 cells. Brain Res. 852: 326-334.
86. Reddy PH. 2009. Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons. Antioxid. Redox Signal. 9: 1647-1658.
87. Rios R, Zarazua S, Santoyo ME, Sepulveda-Saavedra J, Romero-Diaz V, Jimenez V, Perez-Severiano F, Vidal-Cantu G, Delgado JM, Jimenez-Capdeville ME. 2009. Decreased nitric oxide markers and morphological changes in the brain of arsenic-exposed rats. Toxicology 261: 68-75.
88. Rizzuto R, Bernardi P, Pozzan T. 2000. Mitochondria as all-round players of the calcium game. J. Physiol. 529: 37-47.
89. Rocha RA, Gimeno-Alcaniz JV, Martin-Ibanez R, Canals JM, Velez D, Devesa V. 2011. Arsenic and fluoride induce neural progenitor cell apoptosis. Toxicol. Lett. 203: 237-244.
90. Rodriguez VM, Carrizales L, Mendoza MS, Fajardo OR, Giordano M. 2002. Effects of sodium arsenite exposure on development and behavior in the rat. Neurotoxicol. Teratol. 24: 743-570.
91. Rodriguez VM, Limon-Pacheco JH, Carrizales L, Mendoza-Trejo MS, Giordano M. 2010. Chronic exposure to low levels of inorganic arsenic causes alterations in locomotor activity and in the expression of dopaminergic and antioxidant systems in the albino rat. Neurotoxicol. Teratol. 32: 640-647.
92. Rojewski MT, Korper S, Thiel E, Schrezenmeier H. 2004. Arsenic trioxide-induced apoptosis is independent of CD95 in lymphatic cell lines. Oncol. Rep. 11: 509-513.
93. Rosado JL, Ronquillo D, Kordas K, Rojas O, Alatorre J, Lopez P, Garcia-Vargas G, Del Carmen CM, Cebrian ME, Stoltzfus RJ. 2007. Arsenic exposure and cognitive performance in Mexican schoolchildren. Environ. Health Perspect. 115: 1371-1375.
94. Sannadi S, Kadeyala PK, Gottipolu RR. 2013. Reversal effect of monoisoamyl dimercaptosuccinic acid (MiADMSA) for arsenic and lead induced perturbations in apoptosis and antioxidant enzymes in developing rat brain. Int. J. Dev. Neurosci. 31: 586-597.
95. Scorrano L. 2009. Opening the doors to cytochrome c: changes in mitochondrial shape and apoptosis. Int. J. Biochem. Cell Biol. 41: 1875-1883.
96. Shila S, Kokilavani V, Subathra M, Panneerselvam C. 2005a. Brain regional responses in antioxidant system to α-lipoic acid in arsenic intoxicated rat. Toxicology 210: 25-36.
97. Shila S, Subathra M, Devi MA, Panneerselvam C. 2005b. Arsenic intoxication-induced reduction of glutathione level and of the activity of related enzymes in rat brain regions: reversal by dl-alpha-lipoic acid. Arch. Toxicol. 79: 140-146.
98. Sidhu JS, Ponc RA, Vredevoogd MA, Yu X, Gribble E, Hong SW, Schneider E, Faustman EM. 2006. Cell cycle inhibition by sodium arsenite in primary embryonic rat midbrain neuroepithelial cells. Toxicol. Sci. 89: 475-484.
99. Singh AP, Goel RK, Kaur T. 2011. Mechanism pertaining to arsenic toxicity. Toxicol. Int. 18: 87-93.
100. Sinha M, Manna P, Sil PC. 2008. Protective effect of arjunolic acid against arsenic induced oxidative stress in mouse brain. J. Biochem. Mol. Toxicol. 22: 15-26.
101. Srivastava P, Yadav RS, Chandravanshi LP, Shukla RK, Dhuriya YK, Chauhan LK, Dwivedi HN, Pant AB, Khanna VK. 2014. Unraveling the mechanism of neuroprotection of curcumin in arsenic induced cholinergic dysfunctions in rats. Toxicol. Appl. Pharmacol. 279: 428-440.
102. States JC, Barchowsky A, Cartwright IL, Reichard JF, Futscher BW, Lantz RC. 2011. Arsenic toxicology: translating between experimental models and human pathology. Environ. Health Perspect. 119: 1356-1363.
103. Tandon SK, Singh S, Jain VK. 1994. Efficacy of combined chelation in lead intoxication. Chem. Res. Toxicol. 7: 585-589.
104. Thomas DJ, Styblo M, Lin S. 2001. The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176: 127-144.
105. Trushina E, Dyer RB, Badger JD, Ure D, Eide L, Tran DD, Vrieze BT, Legendre-Guillemin V, McPherson PS, Mandavilli BS, Van Houten B, Zeitlin S, McNiven M, Aebersold R, Hayden M, Parisi JE, Seeberg E, Dragatsis I, Doyle K, Bender A, Chacko C, McMurray CT. 2004. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol. Cell. Biol. 24: 8195-8209.
106. Tsai SY, Chou HY, The HW, Chen CM, Chen CJ. 2003. The effects of chronic arsenic exposure on the neurobehavioral development in adolescence. Neurotoxicology 24: 747-753.
107. Vahidnia A, Romijn F, van der Voet GB, deWolff FA. 2008. Arsenic-induced neurotoxicity in relation to toxicokinetics: Effects on sciatic nerve proteins. Chem. Biol. Interact. 176: 188-195.
108. Wang X, Michaelis EK. 2010. Selective neuronal vulnerability to oxidative stress in the brain. Front. Aging Neurosci. 2: 12.
109. Xi S, Guo L, Qi R, Sun W, Jin Y, Sun G. 2010. Prenatal and early life arsenic exposure induced oxidative damage and altered activities and mRNA expressions of neurotransmitter metabolic enzymes in offspring rat brain. J. Biochem. Mol. Toxicol. 24: 368-378.
110. Yadav RS, Sankhwar ML, Shukla RK, Chandra R, Pant AB, Islam F, Khanna VK. 2009. Attenuation of arsenic neurotoxicity by curcumin in rats. Toxicol. Appl. Pharmacol. 240: 367-376.
111. Yadav RS, Shukla RK, Sankhwar ML, Patel DK, Ansari RW, Pant AB, Islam F, Khanna VK. 2010. Neuroprotective effect of curcumin in arsenic-induced neurotoxicity in rats. Neurotoxicology 31: 533-539.
112. Yen CC, Ho TJ, Wu CC, Chang CF, Su CC, Chen YW, Jinn TR, Lu TH, Cheng PW, Su YC, Liu SH, Huang CF. 2011. Inorganic arsenic causes cell apoptosis in mouse cerebrum through an oxidative stress-regulated signaling pathway. Arch. Toxicol. 85: 565-575.
113. Zarazua S, Ríos R, Delgado JM, Santoyo ME, Ortiz-Perez D, Jimenez-Capdeville ME. 2010. Decreased arginine methylation and myelin alterations in arsenic exposed rats. Neurotoxicology 31: 94-100.
114. Zhang W, Feng H, Gao Y, Sun L, Wang J, Li Y, Wang C, Zhao L, Hu X, Sun H, Wei Y, Sun D. 2013. Role of pigment epithelium-derived factor (PEDF) in arsenic-induced cell apoptosis of liver and brain in a rat model. Biol. Trace Elem. Res. 151: 269-276.
115. Zhao F, Liao Y, Jin Y, Li G, Lv X, Sun G. 2012. Effects of arsenite on glutamate metabolism in primary cultured astrocytes. Toxicol. In Vitro 26: 24-31.